Enzolytics Inc (ENZC)

[Wisdom of Locke]

No real need to dig. Some existing info from previous ENZC documents: IMMB sold all of its assets to the entity that ended up being renamed Enzolytics. This included the worldwide licensing agreement issued from Zhabilov Trust the patent owner. (Harry Zhabilov was the inventor.) ENZC acquired 49% interest of IMMB BG. IMMB BG was issued a sub license for the Bulgarian territory and for the Ukraine when IMMB BG entered into the Omega agreement.

All agreements with IMMB BG were cancelled for failure to perform. The only license that is in place is the license granting exclusive rights to the patent to ENZC- including manufacturing rights.

Based on this license agreement between the Trust and ENZC, two distribution agreements have been entered into in 20021; one to the IMPL entity, which is paying for the clinical trials and EMA permitting cost and ENZC owns 50% and a second with an entity that is contributing 50% of a manufacturing facility in Bulgaria once the permit from the EMA is completed. I am sure neither of these two seasoned groups would have invested in a distributorship if there were any other license of the ITV-1 immunotherapy.